Description
PRINCIPIO ACTIVO: HIDROSMINA
Requiere monitoreo clínico continuo durante el tratamiento
indicado para el tratamiento de diversos tipos de cáncer
Flujo moderado
Inmunoglobulina humana normal 100 mg/mL
TRADERMA UNG 0 03% CRA 30G VITAMINA B12 5.00 MG VITAMINA B1 200.00 MG VITAMINA B6 100.00 MG PRINCIPIO ACTIVO: HIDROSMINAPRINCIPIO ACTIVO: TACROLIMUS
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
